Thrombectomy Devices Market Analysis & Forecast to 2028 by Key Players, Share, Trend, Segmentation The thrombectomy devices market is likely to observe notable growth through 2028 on account of growing prevalence of cardiovascular diseases across the globe. Recently, increasing initiatives by industry players in key regions to extend their market presence have augmented market growth significantly. For instance, in March 2022, Medtronic, a key medical device firm, launched the first-ever dedicated clinical registry in India dubbed PRAAN (Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neurothrombectomy Devices in India). It would help examine clinical outcomes in patients treated with the company's revascularization devices, advancing thrombectomy studies and innovations. Browse key industry insights spread across 157 pages with 193 market data tables & 16 figures & charts from the report, “Thrombectomy Devices Market Analysis By Product Type (Ultrasound-assisted Thrombectomy Devices, Rotational Thrombectomy Devices, Aspiration Thrombectomy Devices, Mechanical/Fragmentation Thrombectomy Devices, Clot Extraction Catheter, Stent Retrievers, Microcatheters), Application (Peripheral Thrombectomy, Neurovascular Thrombectomy, Cardiovascular Thrombectomy), End User (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/thrombectomy-devices-market The global thrombectomy devices market has been classified on the basis of product type, application, end-use, and region. Based on product type, the thrombectomy devices industry has been fragmented into stent retrievers, ultrasound-assisted thrombectomy devices, mechanical/fragmentation thrombectomy devices, microcatheters, clot extraction catheter, rotational thrombectomy devices, aspiration thrombectomy devices, and others. Among these, the ultrasound-assisted thrombectomy devices segment is projected to exhibit a CAGR of about 6.5% between 2022 and 2028. Enhanced effectivity of these devices among intermediate risk patients and technological advancements in products are set to contribute to segmental growth. In terms of application, the thrombectomy devices market has been categorized into cardiovascular thrombectomy, peripheral thrombectomy, and neurovascular thrombectomy. The cardiovascular thrombectomy segment was valued at approximately USD 900 million in 2021 and is projected to grow at a steady pace over 2022-2028 owing to resurgence of cardiovascular diseases. Shifting consumer preferences for minimally invasive procedures, coupled with broadening therapeutic applications of thrombectomy devices, are likely to propel product uptake in cardiovascular thrombectomy. By end-use, the thrombectomy devices market has been bifurcated into hospitals, ambulatory surgical centers, and others. In 2021, the hospitals segment surpassed USD 720 million in © 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com